231 & 65 Management Revenue, Growth & Competitor Profile

Company Profile & Annual Report for 231 & 65 Management

Access the complete profile.

231 & 65 Management Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	621511 Medical Laboratories
Address	7921 Grand Blvd Hobart, IN 46342

Note: Revenues for privately held companies are statistical evaluations.


231 & 65 Management's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • 231 & 65 Management's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • 231 & 65 Management is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

231 & 65 Management Annual Revenue and Growth Rate

231 & 65 Management	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: 231 & 65 Management's revenues are gauged from an analysis of company filings.

231 & 65 Management's Income Statement (based on Industry Averages)

231 & 65 Management P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

231 & 65 Management has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 27, 2012	22	97%	$1 MM
Complete list of funding rounds and total amounts in the Company Report

Market Share of 231 & 65 Management's Largest Competitors

A competitive analysis shows these companies are in the same general field as 231 & 65 Management, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to 231 & 65 Management. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ALVERNO PROVENA HOSPITAL LABORATORIES	Hammond, IN	100
ALVERNO CLINICAL LABORATORIES	Hammond, IN	48
231 & 65 MANAGEMENT	Hobart, IN	0
BUYNAK CLINICAL RESEARCH P.C.	Valparaiso, IN	0
PHYSICIANS SURGICAL MANAGEMENT	Hobart, IN	0
LAMBERT DENTAL LABORATORY	Crown Point, IN	0

Future Competition: 231 & 65 Management's Fastest Growing Competitors

These companies are in the same general field as 231 & 65 Management and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)